Jury still out on Viagra, Levitra and Cialis championship race title

Washington, May 19 (ANI): A new report suggests that there is no clear evidence to determine which among the three erectile dysfunction drugs-Viagra, Levitra and Cialis-works best, and which causes the least harm.

Issued by HHS' Agency for Healthcare Research and Quality, the report said that men who took oral phosphodiesterase type 5 inhibitors, also known as PDE-5 inhibitors, had improved erectile function as compared to those who did not take the medication.

However, head-to-head trials comparing Viagra, Levitra, and tadalafil Cialis were inconclusive as to which medication worked best.

The most common short-term side effects in men taking PDE-5 inhibitors were headache, flushing, abdominal pain, and runny nose.

Although the types of reactions varied with the drugs studied, there were no significant differences in side effects associated with either Viagra, Levitra, or Cialis.

Lead reviewer Dr. Alexander Tsertsvadze, of the AHRQ-supported University of Ottawa Evidence-based Practice Center, says that more studies are needed to clarify the best treatment management options for different groups of patients as well as more clinical trials to compare PDE-5 inhibitors to hormonal, injection, and creams or other topical treatments for erectile dysfunction. (ANI)